🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07112586
Starting soon Phase 1/2

Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study

NCT07112586 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 1/2
Started
2025-08-30
Last updated
2025-08-08

Condition(s) studied

Androgenetic Alopecia

Investigational drug(s) / intervention(s)

Plasma derived exosomes

Plasma derived exosomes: Exosomes derived from patients' plasma, centrifuged at high speeds multiple times

Study summary

Intradermal injection of exosomes in treatment of male androgenetic alopecia, clinically and using a immunohistochemical marker

Eligibility

Sex
MALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: \- Androgenetic Alopecia Grades 1-4 Exclusion Criteria: * blood diseases Receiving other treatments History of malignancy or allergic reaction to exosomes

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ain Shams Univeristy Faculty of medicine Cairo Abbasia

More Ain Shams University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07112586 on ClinicalTrials.gov ↗ ← All trials in Egypt